127 related articles for article (PubMed ID: 12162698)
1. Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis.
Shen W; Waldschmidt M; Zhao X; Ratliff T; Krieg AM
Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):155-64. PubMed ID: 12162698
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
3. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
5. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
Zhang Z; Guo K; Schluesener HJ
J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
[TBL] [Abstract][Full Text] [Related]
6. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
[TBL] [Abstract][Full Text] [Related]
7. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
Bjersing JL; Eriksson K; Tarkowski A; Collins LV
Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB-dependent regulation of tumor necrosis factor-alpha gene expression by CpG-oligodeoxynucleotides.
Kwon HJ; Lee KW; Yu SH; Han JH; Kim DS
Biochem Biophys Res Commun; 2003 Nov; 311(1):129-38. PubMed ID: 14575704
[TBL] [Abstract][Full Text] [Related]
9. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
11. CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.
Lee S; Hong J; Choi SY; Oh SB; Park K; Kim JS; Karin M; Lee SJ
J Neuroimmunol; 2004 Aug; 153(1-2):50-63. PubMed ID: 15265663
[TBL] [Abstract][Full Text] [Related]
12. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
Zhao H; Cheng SH; Yew NS
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
[TBL] [Abstract][Full Text] [Related]
13. Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.
Vollmer J; Janosch A; Laucht M; Ballas ZK; Schetter C; Krieg AM
Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):165-75. PubMed ID: 12162699
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
[TBL] [Abstract][Full Text] [Related]
15. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.
Hour MJ; Tsai SC; Wu HC; Lin MW; Chung JG; Wu JB; Chiang JH; Tsuzuki M; Yang JS
Int J Oncol; 2012 Oct; 41(4):1513-9. PubMed ID: 22825655
[TBL] [Abstract][Full Text] [Related]
17. Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations.
De Saint Jean M; Debbasch C; Rahmani M; Brignole F; Feldmann G; Warnet JM; Baudouin C
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2531-43. PubMed ID: 10937564
[TBL] [Abstract][Full Text] [Related]
18. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.
Carpentier AF; Chen L; Maltonti F; Delattre JY
Cancer Res; 1999 Nov; 59(21):5429-32. PubMed ID: 10554011
[TBL] [Abstract][Full Text] [Related]
19. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
[TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA delays human eosinophil apoptosis.
Ilmarinen P; Hasala H; Sareila O; Moilanen E; Kankaanranta H
Pulm Pharmacol Ther; 2009 Jun; 22(3):167-76. PubMed ID: 19073274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]